Today's Rates 11-24-15

Loan Amt:  
Term Rate APR Payment
30 Yr 4.25% 4.25%
Super Conf 30yr 4.375% 4.375%
FHA 3.75% 3.75%
15 Yr 3.75% 3.75%
30 Yr VA 3.75% 3.75%


Free Consultation

Complete the form below to register for a Free Consultation. Please note that fields marked with an asterisk are required.



Home Loan Rates


View Today's Conventional Rates

Please call for VA and FHA Rates

Whether you're looking for home loan rates in Fairfax VA or want to speak with us about getting a 30 year fixed mortgage loan in Virginia Beach VA, we can help. Atlantic Mortgage & Funding is a Virginia based mortgage company providing home loans in 5 states, including Florida, Kentucky, Maryland, Tennessee, and Virginia. We strive to offer great purchase and refinance rates as well as affordable closing costs so that you can get into the home you've worked so hard for.


Today's featured product is a 30 year fixed rate at 3.750 (3.899 APR)
Click Here For More Info!




FHA Loans


Meet Our Staff

Our staff of loan experts are
here to help.

Click to View Our Staff


Apply Now

Use our secure application

Click Here



Market News

Asia stocks stumble on geopolitical tensions, oil stands tall

Passersby walk past in front of stock quotation board outside a brokerage in TokyoBy Shinichi Saoshiro TOKYO (Reuters) - Asian stocks were on edge on Wednesday as geopolitical tensions flared after Turkey downed a Russian fighter jet, while crude oil prices extended gains. MSCI's index of Asia-Pacific stocks outside of Japan edged up 0.1 percent but shares in Hong Kong , Australia and South Korea slipped. Japan's Nikkei shed 0.4 percent.

Exclusive: Shire prepares to make new bid for Baxalta - source

A sign sits in front of Shire's manufacturing facility in Lexington, MassachusettsZURICH/LONDON (Reuters) - Drugmaker Shire is preparing to make a new takeover offer for U.S. biotech firm Baxalta that if successful will create one of the world's leading specialists in rare diseases, a source with direct knowledge of the situation said on Tuesday. Shire's bid preparations come three weeks after it announced its $5.9 billion purchase of U.S. rare disease specialist Dyax Corp . Shire is working with Morgan Stanley , Evercore and Deutsche Bank on the offer which could be structured in cash and shares, the source said, cautioning that no deal was certain and negotiations could still fall through.